PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30743272-6	2019	The patients with ITP undergoing TPO-RA therapy presented a pro-coagulant profile due to the formation of a more fibrinolysis-resistant clot because of increased plasminogen activator inhibitor-1 (PAI-1) levels.	Radium	37-39	serpin family E member 1	Homo sapiens	162-195	
30743272-6	2019	The patients with ITP undergoing TPO-RA therapy presented a pro-coagulant profile due to the formation of a more fibrinolysis-resistant clot because of increased plasminogen activator inhibitor-1 (PAI-1) levels.	Radium	37-39	serpin family E member 1	Homo sapiens	197-202	
11374178-9	2000	The concentration and activity of PAI-1 in the plasma of RA were also much higher than those in the plasma of OA(P < 0.05 and P < 0.0001) and healthy subjects(P < 0.0001 and P < 0.001).	Radium	57-59	serpin family E member 1	Homo sapiens	34-39	
11374178-10	2000	The concentration and activity of PAI-1 in SF and plasma of RA correlated positively.	Radium	60-62	serpin family E member 1	Homo sapiens	34-39	
8363067-8	1993	PAI-1 levels in the GA group increased from 13.6 +/- 2.1 activity units (AU)/ml to 20.2 +/- 2.6 AU/ml at 24 h and returned to baseline at 72 h. In contrast, PAI-1 levels in the RA group remained unchanged over time.	Radium	177-179	serpin family E member 1	Homo sapiens	0-5	
8363067-8	1993	PAI-1 levels in the GA group increased from 13.6 +/- 2.1 activity units (AU)/ml to 20.2 +/- 2.6 AU/ml at 24 h and returned to baseline at 72 h. In contrast, PAI-1 levels in the RA group remained unchanged over time.	Radium	177-179	serpin family E member 1	Homo sapiens	157-162	
29215956-9	2019	Significantly higher levels of F1+2, D-dimer, and PAI-1 were found in ITP patients before TPO-RA treatment and in patients on long-term TPO-RA treatment than in controls.	Radium	94-96	serpin family E member 1	Homo sapiens	50-55